MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2024 International Congress

    OPTN gene associated with corticobasal syndrome: a novel multi-exon deletion and literature review

    G. Bonato, M. Ginevrino, B. Savini, D. Ciprietti, P. Santurelli, E. Gasparoli, C. Gabelli, G. Sorarù, R. Biundo, M. Carecchio, A. Guerra, L. Salviati, A. Antonini (Padova, Italy)

    Objective: To describe a novel case of OPTN multiexon deletion causing a peculiar CBS-ALS phenotype. Background: While traditionally classified as distinct clinical entities, corticobasal syndrome…
  • 2024 International Congress

    Understanding Patient and Care Partner Educational Preferences in Atypical Parkinsonism

    M. Ivancic, M. Comeau, R. Mahabir, C. Malburg, J. Shurer, K. Woods, E. Zivin, CY. Lin (Chapel Hill, USA)

    Objective: To discern preferences for education and community connection among people affected by progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or multiple system atrophy (MSA).…
  • 2024 International Congress

    Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment

    D. Taniguchi, T. Hatano, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: This study monitored the formation of CBD (corticobasal degeneration)-type fibrils that exhibit astrocytic plaques, a characteristic CBD pathology, using Legumain-cleavage site-specific antibodies and CBD-specific…
  • 2024 International Congress

    Environmental risk factors and demographic of patients with Progressive Supranuclear Palsy from Argentina

    F. Rellan, B. Couto, F. Gonzalez Del-Boca, M. Paez Magio, C. Villa, E. Franchello, G. Alvarado, G. Mizraji, D. Nadile, C. Tanner, O. Gershanik, C. Marras (Buenos Aires, Argentina)

    Objective: To describe the environmental risk factors and family history in Argentinian patients with diagnosis of progressive supranuclear palsy (PSP). Background: Background: The current epidemiology…
  • 2024 International Congress

    Identification of underlying Lewy body pathology in primary tauopathies by α-synuclein seed amplification assay

    L. Concha-Marambio, C. Farris, S. Weber, Y. Ma, T. Tropea, D. Irwin, A. Siderowf, B. Mollenhauer (san diego, USA)

    Objective: To determine intravitam prevalence of α-synuclein (αSyn) pathology in primary tauopathies, such as PSP and CBS, by αSyn seed amplification assay (synSAA) Background: Neuropathological…
  • 2024 International Congress

    Pisa Syndrome as an early presenting feature of Corticobasal Ganglionic degeneration [CBGD]

    M. Matta, N. Sawal, A. Prasad (Chandigarh, India)

    Objective: To describe Pisa syndrome as an early presenting feature of CBGD and add to literature on CBGD so that neurologists can suspect CBGD when…
  • 2023 International Congress

    Brain FDG-PET-MRI for early diagnosis of corticobasal syndrome

    I. Guan, C. Stahl, K. Astudillo, T. Shepherd, S. Frucht, G. Riboldi (New York, USA)

    Objective: To characterize brain fluorodeoxyglucose (FDG) PET-MRI findings in patients with corticobasal syndrome (CBS) and evaluate its utility in early diagnosis of Corticobasal Degeneration (CBD)…
  • 2023 International Congress

    Determinants of care partner burden in atypical parkinsonian syndromes

    M. Ivancic, J. Shurer, M. Schmidt, V. Nesspor, M. Li, Y. Lin, R. Xu, G. Schumock, M. Sklerov, A. Pantelyat (Chapel Hill, USA)

    Objective: To understand the determinants of burden among people caring for individuals diagnosed with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), or multiple system atrophy…
  • 2023 International Congress

    Early-onset cortico-basal degeneration (CBD) due to a c.2092G>A MAPT mutation

    M. Mata Alvarez-Santullano, L. Lopez-Manzanares, J. Lopez-Lozano, N. Villares, C. Magdaleno, C. Dela Torre (Madrid, Spain)

    Objective: To describe a patient with early-onset atypical parkinsonism that evolved to a classic CBD without dementia, associated to a c.2092G>A MAPT mutation Background: Although…
  • 2023 International Congress

    Autoimmune encephalitis due to antiglycine antibodies presenting as corticobasal syndrome

    S. Secades (Madrid, Spain)

    Objective: To describe a complex case of atypical parkinsonism compatible with corticobasal syndrome (CBS), associated with autoimmune findings in serum and cerebrospinal fluid (CSF) and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley